Article Information
PubMed
Published By
History
- Received September 29, 2017
- Returned for modification October 25, 2017
- Accepted January 14, 2018
- Published online March 22, 2018.
Copyright & Usage
Copyright © 2018 American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers
- Judith A. Appleton, Editor, Cornell University
Article Versions
- Accepted Manuscript version (January 22, 2018).
- You are viewing the most recent version of this article.
Author Information
- Romain A. Colasa*,
- Anthony W. Ashtonb,
- Shankar Mukherjeec,
- Jesmond Dallia*,
- Oscar B. Akide-Ndungec,
- Huan Huangc,
- Mahalia S. Desruisseauxc,d,
- Fangxia Guanc,g,
- Linda A. Jelickse,
- Fabiane Matos dos Santosc,
- Jyothi Nagajyothif,
- Michael A. Zingmanc*,
- Jinet Reyesc,
- Louis M. Weissc,d,
- Charles N. Serhana and
- Herbert B. Tanowitzc,d
- aCenter for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
- bKolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, NSW, Australia
- cDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York, USA
- dDepartment of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
- eDepartment of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, New York, USA
- fPublic Health Research Institute Center at the International Center for Public Health, New Jersey Medical School—Rutgers, The State University of New Jersey, Rutgers, New Jersey, USA
- gSchool of Life Sciences, Zhengzhou University, Zhengzhou, China
- Address correspondence to Herbert B. Tanowitz, herbert.tanowitz{at}einstein.yu.edu.
↵* Present address: Romain A. Colas and Jesmond Dalli, Lipid Mediator Unit, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom; Michael A. Zingman, Columbia University College of Physicians and Surgeons, New York, New York, USA.
R.A.C. and A.W.A. contributed equally to this work.
Citation Colas RA, Ashton AW, Mukherjee S, Dalli J, Akide-Ndunge OB, Huang H, Desruisseaux MS, Guan F, Jelicks LA, Matos dos Santos F, Nagajyothi J, Zingman MA, Reyes J, Weiss LM, Serhan CN, Tanowitz HB. 2018. Trypanosoma cruzi produces the specialized proresolving mediators resolvin D1, resolvin D5, and resolvin E2. Infect Immun 86:e00688-17. https://doi.org/10.1128/IAI.00688-17.